Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $656K (3,415 shares) of Jazz Pharmaceuticals plc on Feb 27, 2026. Filing
- Last sale before this period: Aug 14, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | May 13, 2013 | Sep 2, 2026 |
| Baxter International (BAX) | Former Corporate Vice President | Aug 4, 2003 | Jan 18, 2013 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Jazz Pharmaceuticals plc: 1,706 shares withheld by the company for taxes. 1 filing: 1
- Aug 5, 2026, Jazz Pharmaceuticals plc: 1,605 shares granted. 1 filing: 1
- Feb 27, 2026, Jazz Pharmaceuticals plc: sold 3,415 shares for $656K, no plan disclosed; 3,415 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.